SCHEMBL21313933

SCHEMBL21313933

O=C(/C=C/c1ccc(OC(F)(F)F)cc1)N1CC=C2CN(Cc3ccc4[nH]nnc4c3)C[C@H]2CC1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.40
▸ GPR183 P32249 5/20 0.39
▸ ENPP2 Q13822 3/20 0.38
▸ ATXN2 Q99700 1/20 0.38
▸ CCR2 P41597 1/20 0.37
▸ FPR2 P25090 1/20 0.36
▸ CA2 P00918 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ACHE P22303 1/20 0.34
▸ ROCK2 O75116 1/20 0.34
▸ MCHR1 Q99705 1/20 0.34
▸ LSS P48449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17311093 1.00 NAMPT (0.45) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL21323332 0.86 NAMPT (0.50) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL17311092 0.86 NAMPT (0.50) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL17311095 0.86 NAMPT (0.50) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL16962509 0.86 APP (0.40) GPR183ACHE
SCHEMBL21313914 0.86 APP (0.40) GPR183ACHE
SCHEMBL16963871 0.85 NAMPT (0.47) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL16962048 0.77 ALDH1A1 (0.48) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL21313870 0.76 HRH3 (0.40) NAMPTHRH3GPR183ENPP2ATXN2
SCHEMBL16963158 0.76 HRH3 (0.40) NAMPTHRH3GPR183ENPP2ATXN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback